Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011
In China, the chemical pharmaceutical industry includes the chemical API industry and the chemical preparation industry.
The chemical active pharmaceutical ingredients (API) manufacture refers to the production of APIs demanded in the further processing of preparations. It mainly includes the production of chemical substances such as antibiotics, incretions, essential vitamins, etc. The chemical preparation manufacture refers to the production of chemical drug preparations that are directly used for the prevention, treatment and diagnosis of human diseases. These preparations include tablets, injections, capsules, etc. As a sub-industry of the medicine industry, the chemical pharmaceutical industry is attributed to the sector of necessary consumer goods. Therefore, it is not sensitive to the cyclic fluctuation of the macro economy and the international economic environment.
Chinese chemical pharmaceutical industry has its strong points and weak points. On one hand, the chemical API industry shows great advantages in the production scale, market share, techniques and technologies. On the other hand, Chinese chemical preparation industry has low development level and less competitiveness. In China, over 95% homemade medicines are generic ones. The patent drug and expired patent drug (brand-name drug) market is almost totally occupied by foreign-funded or joint venture medicine enterprises. The technological level of Chinese local pharmaceutical enterprises generally lags behind that of transnational pharmaceutical enterprises. Chinese local pharmaceutical enterprises produce medicines mainly by imitation, which is complemented with some innovation. China is now a large export country of chemical APIs.
In 2009, the total sales in Chinese chemical pharmaceutical industry reached CNY 424.24 billion, rising by 18.24% YOY. In 2009, China’s total import and export value of chemical medicines amounted to USD 32.79 billion, rising by 8.03% YOY. The export value was USD 19.20 billion, dropping by 0.8% YOY; the import value was USD 13.59 billion, rising by 23.59% YOY.
In the heavily-populated China, the medicine consumption capacity will be improved with the increase of residents’ income and the intensification of their healthcare awareness. Moreover, the volume of the elderly in China is rising, and they are one of the largest consumer groups of medicines. With the constant reform and perfection of China’s medical system and the enhancement of the universality and fairness of the social security system, the seriously suppressed demand in the medicine market will gradually be released.
Through this report, readers can acquire more information:
The chemical active pharmaceutical ingredients (API) manufacture refers to the production of APIs demanded in the further processing of preparations. It mainly includes the production of chemical substances such as antibiotics, incretions, essential vitamins, etc. The chemical preparation manufacture refers to the production of chemical drug preparations that are directly used for the prevention, treatment and diagnosis of human diseases. These preparations include tablets, injections, capsules, etc. As a sub-industry of the medicine industry, the chemical pharmaceutical industry is attributed to the sector of necessary consumer goods. Therefore, it is not sensitive to the cyclic fluctuation of the macro economy and the international economic environment.
Chinese chemical pharmaceutical industry has its strong points and weak points. On one hand, the chemical API industry shows great advantages in the production scale, market share, techniques and technologies. On the other hand, Chinese chemical preparation industry has low development level and less competitiveness. In China, over 95% homemade medicines are generic ones. The patent drug and expired patent drug (brand-name drug) market is almost totally occupied by foreign-funded or joint venture medicine enterprises. The technological level of Chinese local pharmaceutical enterprises generally lags behind that of transnational pharmaceutical enterprises. Chinese local pharmaceutical enterprises produce medicines mainly by imitation, which is complemented with some innovation. China is now a large export country of chemical APIs.
In 2009, the total sales in Chinese chemical pharmaceutical industry reached CNY 424.24 billion, rising by 18.24% YOY. In 2009, China’s total import and export value of chemical medicines amounted to USD 32.79 billion, rising by 8.03% YOY. The export value was USD 19.20 billion, dropping by 0.8% YOY; the import value was USD 13.59 billion, rising by 23.59% YOY.
In the heavily-populated China, the medicine consumption capacity will be improved with the increase of residents’ income and the intensification of their healthcare awareness. Moreover, the volume of the elderly in China is rising, and they are one of the largest consumer groups of medicines. With the constant reform and perfection of China’s medical system and the enhancement of the universality and fairness of the social security system, the seriously suppressed demand in the medicine market will gradually be released.
Through this report, readers can acquire more information:
- Status quo of Chinese chemical pharmaceutical industry
- Competition in Chinese chemical pharmaceutical industry
- Status quo of Chinese API industry
- Development of Chinese chemical pharmaceutical industry by region
- Operation of major enterprises in Chinese chemical pharmaceutical industry
- Import and export of Chinese chemical pharmaceutical industry
- Prediction on development of Chinese chemical pharmaceutical industry
- Prediction on investment of Chinese chemical pharmaceutical industry
- Medicine producers
- Medicine traders
- Medicine R&D institutes
- Investors concerning Chinese medicine industry
- Research institutes concerning Chinese medicine industry
- Correlative enterprises along the medicine industry chain
1 OVERVIEW OF CHEMICAL PHARMACEUTICAL INDUSTRY
1.1 Definition and Classification of Chemical Pharmaceutical Industry in China
1.2 Status of the Chemical Pharmaceutical Industry in Chinese National Economy
2 ANALYSIS OF DEVELOPMENT ENVIRONMENT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
2.1 Analysis of Macroeconomic Environment
2.1.1 China’s National Economic Situation
2.1.2 Urban Fixed Asset Investment Maintained Fast Growth
2.1.3 Total Retail Sales of Consumer Goods
2.1.4 Easy Monetary Policy
2.2 Analysis of Policy Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.2.1 Analysis of Major Policies
2.2.2 Analysis of Major Events
2.2.3 Prediction on Development Tendency of Policies
2.3 Analysis of Social Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.3.1 Growing Population
2.3.2 Growing Urbanization
2.3.3 Population Aging
2.3.4 Effective Demand Generated by Income Growth
2.4 Analysis of Technical Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.4.1 Comparison of Domestic and Foreign Technologies
2.4.2 Labor Productivity in 2009
2.4.3 Tendency of New Chemical Pharmaceutical Technologies
3 ANALYSIS OF DEVELOPMENT STATUS OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
3.1 Analysis of the Scale of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.2 Analysis and Prediction on the Supply of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.2.1 Total Supply
3.2.2 Supply Structure
3.2.3 Prediction on Supply
3.3 Analysis and Prediction on the Demand of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.3.1 Total Demand
3.3.2 Consumption Structure
3.3.3 Prediction on Demand
3.4 Analysis of the Price in Chinese Chemical Pharmaceutical Industry, 2009-2010
3.4.1 Price Change
3.4.2 Prediction on Price
3.5 Analysis of Investment and Financing in Chinese Chemical Pharmaceutical Industry, 2009-2010
3.5.1 Sources of Funds
3.5.2 Fixed Asset Investment
3.5.3 M&A Situation
3.5.4 Investment Characteristics
4 ANALYSIS OF COMPETITION IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY
4.1 Analysis and Prediction on Concentration of Chinese Chemical Pharmaceutical Industry, 2009
4.1.1 Analysis on Concentration Situation
4.1.2 Prediction on Concentration, 2010-2011
4.2 Analysis on Entry and Exit Barriers in Chinese Chemical Pharmaceutical Industry, 2009-2010
4.2.1 Fund Barrier
4.2.2 Technology Barrier
4.2.3 Policy Barrier
4.3 Analysis of Competition Structure in Chinese Chemical Pharmaceutical Industry, 2009-2010
4.3.1 Bargaining Power of Upstream Suppliers
4.3.2 Competition among Existing Enterprises
4.3.3 Bargaining Power of Downstream Users
4.3.4 Threats from New Entrants
4.3.5 Threats from Substitutes
4.4 Analysis on Lifecycle of Chinese Chemical Pharmaceutical Industry, 2009
5 ANALYSIS ON IMPORT AND EXPORT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009
5.1 Analysis on Import
5.1.1 Import of Chemical APIs
5.1.2 Import of Chemical Preparations
5.2 Analysis on Export
5.2.1 Export of Chemical APIs
5.2.2 Export of Chemical Preparations
6 ANALYSIS ON INDUSTRY CHAIN OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
6.1 Introduction to Industry Chain of Chinese Chemical Pharmaceutical Industry, 2009-2010
6.2 Analysis on Upstream Industries of Chemical Pharmaceutical Industry, 2009-2010
6.2.1 Chemical Industry
6.2.2 Petroleum Industry
6.2.3 Influence of Upstream Industries on Chemical Pharmaceutical Industry
6.3 Analysis on Downstream Industries of the Chemical Pharmaceutical Industry, 2009
6.3.1 Sales of the Medicine Industry
6.3.2 Operation of the Medicine Retail Industry
6.3.3 Prediction on Development of the Medicine Retail Industry
6.3.4 Influence of Downstream Industries on the Chemical Pharmaceutical Industry
7 ANALYSIS ON CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY BY REGION, 2009-2010
7.1 Analysis on Regional Distribution of Chinese Chemical Pharmaceutical Industry
7.1.1 Regional Distribution Characteristics
7.1.2 Scale Indicators by Region
7.1.3 Effectiveness Indicators by Region
7.2 Analysis on Development of Jiangsu Chemical Pharmaceutical Industry
7.2.1 Overview
7.2.2 Economic Operation
7.2.3 Prediction on Development
7.3 Analysis on Development of Shandong Chemical Pharmaceutical Industry
7.3.1 Overview
7.3.2 Economic Operation
7.3.3 Prediction on Development
7.4 Analysis on Development of Zhejiang Chemical Pharmaceutical Industry
7.4.1 Overview
7.4.2 Economic Operation
7.4.3 Prediction on Development
8 ANALYSIS ON CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY BY SUB-INDUSTRY, 2009-2010
8.1 Development of Chinese Chemical API Industry, 2009-2010
8.1.1 Industry Scale
8.1.2 Supply and Demand
8.1.3 Financial Status
8.1.4 Operation Characteristics
8.1.5 Development Tendency
8.2 Development of Chinese Chemical Preparation Industry, 2009-2010
8.2.1 Industry Scale
8.2.2 Supply and Demand
8.2.3 Financial Status
8.2.4 Operation Characteristics
8.2.5 Development Tendency
9 ANALYSIS OF MAJOR ENTERPRISES IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
9.1 Analysis of Enterprises’ Overall Characteristics
9.1.1 Medium Enterprises’ Asset Scale Takes the Lead
9.1.2 Small Enterprises Acquire the Highest Sales Growth Rate
9.1.3 Employee Proportion of Medium Enterprises is the Largest
9.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
9.2.1 Company Profile
9.2.2 Operation
9.2.3 Leading Products
9.2.4 Operating and Development Strategies
9.2.5 SWOT Analysis
9.3 Jiangsu Hengrui Medicine Co., Ltd
9.3.1 Company Profile
9.3.2 Operation
9.3.3 Leading Products
9.3.4 Operating and Development Strategies
9.3.5 SWOT Analysis
9.4 Sichuan Dikang Sci & Tech Pharmaceutical Industry Co., Ltd
9.4.1 Company Profile
9.4.2 Operation
9.4.3 Leading Products
9.4.4 Operating and Development Strategies
9.4.5 SWOT Analysis
9.5 Jinling Pharmaceutical Co., Ltd
9.5.1 Company Profile
9.5.2 Operation
9.5.3 Leading Products
9.5.4 Operating and Development Strategies
9.5.5 SWOT Analysis
9.6 Mayinglong Pharmaceutical Group Co., Ltd
9.6.1 Company Profile
9.6.2 Financial Status
9.6.3 Leading Products
9.6.4 Operating and Development Strategies
9.6.5 SWOT Analysis
10 ANALYSIS ON RISKS IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2010
10.1 Macroeconomic Fluctuation Risk
10.2 Policy Risk
10.3 Technical Risk
10.4 Correlated Industry Risk
10.5 Regional Risk
10.6 Product Structure Risk
10.7 Other Risks
11 RECOMMENDATIONS TO INVESTMENT AND DEVELOPMENT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2011-2012
11.1 Prediction on Investment Opportunities
11.2 Investment and Development Recommendations
1.1 Definition and Classification of Chemical Pharmaceutical Industry in China
1.2 Status of the Chemical Pharmaceutical Industry in Chinese National Economy
2 ANALYSIS OF DEVELOPMENT ENVIRONMENT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
2.1 Analysis of Macroeconomic Environment
2.1.1 China’s National Economic Situation
2.1.2 Urban Fixed Asset Investment Maintained Fast Growth
2.1.3 Total Retail Sales of Consumer Goods
2.1.4 Easy Monetary Policy
2.2 Analysis of Policy Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.2.1 Analysis of Major Policies
2.2.2 Analysis of Major Events
2.2.3 Prediction on Development Tendency of Policies
2.3 Analysis of Social Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.3.1 Growing Population
2.3.2 Growing Urbanization
2.3.3 Population Aging
2.3.4 Effective Demand Generated by Income Growth
2.4 Analysis of Technical Environment of Chinese Chemical Pharmaceutical Industry, 2009-2010
2.4.1 Comparison of Domestic and Foreign Technologies
2.4.2 Labor Productivity in 2009
2.4.3 Tendency of New Chemical Pharmaceutical Technologies
3 ANALYSIS OF DEVELOPMENT STATUS OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
3.1 Analysis of the Scale of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.2 Analysis and Prediction on the Supply of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.2.1 Total Supply
3.2.2 Supply Structure
3.2.3 Prediction on Supply
3.3 Analysis and Prediction on the Demand of Chinese Chemical Pharmaceutical Industry, 2009-2010
3.3.1 Total Demand
3.3.2 Consumption Structure
3.3.3 Prediction on Demand
3.4 Analysis of the Price in Chinese Chemical Pharmaceutical Industry, 2009-2010
3.4.1 Price Change
3.4.2 Prediction on Price
3.5 Analysis of Investment and Financing in Chinese Chemical Pharmaceutical Industry, 2009-2010
3.5.1 Sources of Funds
3.5.2 Fixed Asset Investment
3.5.3 M&A Situation
3.5.4 Investment Characteristics
4 ANALYSIS OF COMPETITION IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY
4.1 Analysis and Prediction on Concentration of Chinese Chemical Pharmaceutical Industry, 2009
4.1.1 Analysis on Concentration Situation
4.1.2 Prediction on Concentration, 2010-2011
4.2 Analysis on Entry and Exit Barriers in Chinese Chemical Pharmaceutical Industry, 2009-2010
4.2.1 Fund Barrier
4.2.2 Technology Barrier
4.2.3 Policy Barrier
4.3 Analysis of Competition Structure in Chinese Chemical Pharmaceutical Industry, 2009-2010
4.3.1 Bargaining Power of Upstream Suppliers
4.3.2 Competition among Existing Enterprises
4.3.3 Bargaining Power of Downstream Users
4.3.4 Threats from New Entrants
4.3.5 Threats from Substitutes
4.4 Analysis on Lifecycle of Chinese Chemical Pharmaceutical Industry, 2009
5 ANALYSIS ON IMPORT AND EXPORT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009
5.1 Analysis on Import
5.1.1 Import of Chemical APIs
5.1.2 Import of Chemical Preparations
5.2 Analysis on Export
5.2.1 Export of Chemical APIs
5.2.2 Export of Chemical Preparations
6 ANALYSIS ON INDUSTRY CHAIN OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
6.1 Introduction to Industry Chain of Chinese Chemical Pharmaceutical Industry, 2009-2010
6.2 Analysis on Upstream Industries of Chemical Pharmaceutical Industry, 2009-2010
6.2.1 Chemical Industry
6.2.2 Petroleum Industry
6.2.3 Influence of Upstream Industries on Chemical Pharmaceutical Industry
6.3 Analysis on Downstream Industries of the Chemical Pharmaceutical Industry, 2009
6.3.1 Sales of the Medicine Industry
6.3.2 Operation of the Medicine Retail Industry
6.3.3 Prediction on Development of the Medicine Retail Industry
6.3.4 Influence of Downstream Industries on the Chemical Pharmaceutical Industry
7 ANALYSIS ON CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY BY REGION, 2009-2010
7.1 Analysis on Regional Distribution of Chinese Chemical Pharmaceutical Industry
7.1.1 Regional Distribution Characteristics
7.1.2 Scale Indicators by Region
7.1.3 Effectiveness Indicators by Region
7.2 Analysis on Development of Jiangsu Chemical Pharmaceutical Industry
7.2.1 Overview
7.2.2 Economic Operation
7.2.3 Prediction on Development
7.3 Analysis on Development of Shandong Chemical Pharmaceutical Industry
7.3.1 Overview
7.3.2 Economic Operation
7.3.3 Prediction on Development
7.4 Analysis on Development of Zhejiang Chemical Pharmaceutical Industry
7.4.1 Overview
7.4.2 Economic Operation
7.4.3 Prediction on Development
8 ANALYSIS ON CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY BY SUB-INDUSTRY, 2009-2010
8.1 Development of Chinese Chemical API Industry, 2009-2010
8.1.1 Industry Scale
8.1.2 Supply and Demand
8.1.3 Financial Status
8.1.4 Operation Characteristics
8.1.5 Development Tendency
8.2 Development of Chinese Chemical Preparation Industry, 2009-2010
8.2.1 Industry Scale
8.2.2 Supply and Demand
8.2.3 Financial Status
8.2.4 Operation Characteristics
8.2.5 Development Tendency
9 ANALYSIS OF MAJOR ENTERPRISES IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2009-2010
9.1 Analysis of Enterprises’ Overall Characteristics
9.1.1 Medium Enterprises’ Asset Scale Takes the Lead
9.1.2 Small Enterprises Acquire the Highest Sales Growth Rate
9.1.3 Employee Proportion of Medium Enterprises is the Largest
9.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
9.2.1 Company Profile
9.2.2 Operation
9.2.3 Leading Products
9.2.4 Operating and Development Strategies
9.2.5 SWOT Analysis
9.3 Jiangsu Hengrui Medicine Co., Ltd
9.3.1 Company Profile
9.3.2 Operation
9.3.3 Leading Products
9.3.4 Operating and Development Strategies
9.3.5 SWOT Analysis
9.4 Sichuan Dikang Sci & Tech Pharmaceutical Industry Co., Ltd
9.4.1 Company Profile
9.4.2 Operation
9.4.3 Leading Products
9.4.4 Operating and Development Strategies
9.4.5 SWOT Analysis
9.5 Jinling Pharmaceutical Co., Ltd
9.5.1 Company Profile
9.5.2 Operation
9.5.3 Leading Products
9.5.4 Operating and Development Strategies
9.5.5 SWOT Analysis
9.6 Mayinglong Pharmaceutical Group Co., Ltd
9.6.1 Company Profile
9.6.2 Financial Status
9.6.3 Leading Products
9.6.4 Operating and Development Strategies
9.6.5 SWOT Analysis
10 ANALYSIS ON RISKS IN CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2010
10.1 Macroeconomic Fluctuation Risk
10.2 Policy Risk
10.3 Technical Risk
10.4 Correlated Industry Risk
10.5 Regional Risk
10.6 Product Structure Risk
10.7 Other Risks
11 RECOMMENDATIONS TO INVESTMENT AND DEVELOPMENT OF CHINESE CHEMICAL PHARMACEUTICAL INDUSTRY, 2011-2012
11.1 Prediction on Investment Opportunities
11.2 Investment and Development Recommendations
SELECTED CHARTS
Chart Sub-industries of Chinese Chemical Pharmaceutical Industry
Chart Contribution of the Chemical Pharmaceutical Industry to China’s National Economy
Chart Policies Related to Chinese Chemical Pharmaceutical Industry, 2009-2010
Chart Major Indicators of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Total Output Value of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Total Output Value of Chinese Chemical API Industry, 2005-2009
Chart Total Output Value of Chinese Chemical Preparation Industry, 2005-2009
Chart Projects under Construction in Chinese Chemical Pharmaceutical Industry, 2009-2010
Chart Sales Revenue of Sub-Industries of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Regional Distribution of Assets of Chinese Chemical Pharmaceutical Industry, 2009
Chart Major Financial Indicators of Jiangsu Chemical Pharmaceutical Industry, 2005-2009
Chart Major Indicators of Chinese Chemical API Industry, 2005-2009
Chart Major Indicators of Chinese Chemical Preparation Industry, 2005-2009
Chart Number of Employees in Chinese Chemical Pharmaceutical Industry, 2009
Chart Operation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2006-2010
Chart Operation of Jiangsu Hengrui Medicine Co., Ltd, 2006-2010
Chart SWOT Analysis of Jiangsu Hengrui Medicine Co., Ltd
Chart Operation of Jinling Pharmaceutical Co., Ltd, 2005-2009
Chart Sub-industries of Chinese Chemical Pharmaceutical Industry
Chart Contribution of the Chemical Pharmaceutical Industry to China’s National Economy
Chart Policies Related to Chinese Chemical Pharmaceutical Industry, 2009-2010
Chart Major Indicators of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Total Output Value of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Total Output Value of Chinese Chemical API Industry, 2005-2009
Chart Total Output Value of Chinese Chemical Preparation Industry, 2005-2009
Chart Projects under Construction in Chinese Chemical Pharmaceutical Industry, 2009-2010
Chart Sales Revenue of Sub-Industries of Chinese Chemical Pharmaceutical Industry, 2005-2009
Chart Regional Distribution of Assets of Chinese Chemical Pharmaceutical Industry, 2009
Chart Major Financial Indicators of Jiangsu Chemical Pharmaceutical Industry, 2005-2009
Chart Major Indicators of Chinese Chemical API Industry, 2005-2009
Chart Major Indicators of Chinese Chemical Preparation Industry, 2005-2009
Chart Number of Employees in Chinese Chemical Pharmaceutical Industry, 2009
Chart Operation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2006-2010
Chart Operation of Jiangsu Hengrui Medicine Co., Ltd, 2006-2010
Chart SWOT Analysis of Jiangsu Hengrui Medicine Co., Ltd
Chart Operation of Jinling Pharmaceutical Co., Ltd, 2005-2009
